Tower Research Capital LLC (Trc) Landec Corp \Ca\ Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,005 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,005
Previous 2,832
6.11%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding LNDC
# of Institutions
101Shares Held
23.9MCall Options Held
0Put Options Held
20.7K-
Wynnefield Capital Inc New York, NY4.7MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA4.46MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT3.69MShares$00.0% of portfolio
-
325 Capital LLC New York, NY2.16MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...